{"transactions":[{"id":765843,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765842,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765841,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765840,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":18222,"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765839,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":19697,"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":774869,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:27.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":26758,"source":{"system":"sec-edgar","filing":"0001450485-26-000009","document":"form4-05182026_040516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000009/form4-05182026_040516.xml","form_type":"4"}},{"id":776963,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:05:10.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":35.9691,"value":161860.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.55 to $36.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18017,"source":{"system":"sec-edgar","filing":"0001450485-26-000007","document":"form4-05152026_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000007/form4-05152026_040505.xml","form_type":"4"}},{"id":809613,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-04-13T21:09:47.000Z","date":"2026-04-11","kind":"exercise","planned":false,"acquired":false,"shares":3751,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."}],"balance_after":3752,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3751},"source":{"system":"sec-edgar","filing":"0001520262-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000070/form4.xml","form_type":"4"}},{"id":809612,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-04-13T21:09:47.000Z","date":"2026-04-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":901,"price":33.36,"value":30057.36,"ownership":{"direct":true},"balance_after":13555,"source":{"system":"sec-edgar","filing":"0001520262-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000070/form4.xml","form_type":"4"}},{"id":809611,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-04-13T21:09:47.000Z","date":"2026-04-11","kind":"exercise","planned":false,"acquired":true,"shares":3751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":14456,"source":{"system":"sec-edgar","filing":"0001520262-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000070/form4.xml","form_type":"4"}},{"id":944368,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-07T21:13:32.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":false,"shares":75133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three ratable annual installments beginning January 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three ratable annual installments beginning January 6, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":75133},"source":{"system":"sec-edgar","filing":"0001450485-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000005/primarydocument.xml","form_type":"4"}},{"id":944367,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T21:13:32.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":true,"shares":75133,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":294346,"source":{"system":"sec-edgar","filing":"0001450485-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000005/primarydocument.xml","form_type":"4"}},{"id":946556,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:07:44.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":12666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three ratable annual installments beginning January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three ratable annual installments beginning January 5, 2025."}],"balance_after":12667,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12666},"source":{"system":"sec-edgar","filing":"0001450485-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000003/primarydocument.xml","form_type":"4"}},{"id":946555,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:07:44.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":17.48,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001450485-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000003/primarydocument.xml","form_type":"4"}},{"id":946554,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:07:44.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":12666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":219213,"source":{"system":"sec-edgar","filing":"0001450485-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000003/primarydocument.xml","form_type":"4"}},{"id":978938,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-05T21:06:58.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":9300,"price":15.1051,"value":140477.43,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.95 to $15.36. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. average price."}],"balance_after":206547,"source":{"system":"sec-edgar","filing":"0001450485-25-000009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048525000009/primarydocument.xml","form_type":"4"}},{"id":985006,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:09:54.000Z","date":"2025-11-28","kind":"sale","planned":true,"acquired":false,"shares":500,"price":14.95,"value":7475.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price as these shares were sold in multiple transactions. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":215847,"source":{"system":"sec-edgar","filing":"0001450485-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048525000007/primarydocument.xml","form_type":"4"}},{"id":985005,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:09:54.000Z","date":"2025-11-26","kind":"sale","planned":true,"acquired":false,"shares":200,"price":14.95,"value":2990.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price as these shares were sold in multiple transactions. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":216347,"source":{"system":"sec-edgar","filing":"0001450485-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048525000007/primarydocument.xml","form_type":"4"}},{"id":1088538,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-07-11T20:06:55.000Z","date":"2025-07-10","kind":"exercise","planned":false,"acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vests in three ratable annual installments beginning July 10, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vests in three ratable annual installments beginning July 10, 2024."}],"balance_after":11112,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001562180-25-005390","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005390/primarydocument.xml","form_type":"4"}},{"id":1088537,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-11T20:06:55.000Z","date":"2025-07-10","kind":"exercise","planned":false,"acquired":true,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":216547,"source":{"system":"sec-edgar","filing":"0001562180-25-005390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005390/primarydocument.xml","form_type":"4"}},{"id":1095048,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":true,"shares":27270,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 5, 2028."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":27270,"derivative":{"exercise_price":20.4,"expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":27270},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095047,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":false,"shares":27270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 5, 2028."}],"balance_after":49730,"derivative":{"exercise_price":20.4,"expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":27270},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095046,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":true,"shares":15278,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until July 10, 2027."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":31944,"derivative":{"exercise_price":9.11,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":15278},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095045,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":false,"shares":15278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until July 10, 2027."}],"balance_after":34722,"derivative":{"exercise_price":9.11,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":15278},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095044,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":true,"shares":103308,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 6, 2027."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":272358,"derivative":{"exercise_price":3.26,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":103308},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095043,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":false,"shares":103308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 6, 2027."}],"balance_after":178442,"derivative":{"exercise_price":3.26,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":103308},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095042,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":200000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095041,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."}],"balance_after":40000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095040,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":true,"shares":31165,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":213700,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":31165},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1095039,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:58.000Z","date":"2025-07-02","kind":"gift","planned":false,"acquired":false,"shares":31165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full."}],"balance_after":0,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":31165},"source":{"system":"sec-edgar","filing":"0001562180-25-005229","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025005229/primarydocument.xml","form_type":"4"}},{"id":1127540,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-06-02T20:31:16.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":false,"shares":8013,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001127602-25-016202","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225016202/form4.xml","form_type":"4"}},{"id":1127539,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-06-02T20:31:16.000Z","date":"2025-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1924,"price":30.61,"value":58893.64,"ownership":{"direct":true},"balance_after":10705,"source":{"system":"sec-edgar","filing":"0001127602-25-016202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225016202/form4.xml","form_type":"4"}},{"id":1127538,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-06-02T20:31:16.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":true,"shares":8013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":12629,"source":{"system":"sec-edgar","filing":"0001127602-25-016202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225016202/form4.xml","form_type":"4"}},{"id":1135190,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-05-23T21:58:21.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":6142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/21/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/21/2026."}],"balance_after":6142,"derivative":{"exercise_date":"2026-05-21","underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001127602-25-015541","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225015541/form4.xml","form_type":"4"}},{"id":1135189,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2025-05-23T21:58:21.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":13474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 5/21/2026."}],"balance_after":13474,"derivative":{"exercise_price":30.53,"exercise_date":"2026-05-21","expiration_date":"2035-05-21","underlying":"Ordinary Shares","underlying_shares":13474},"source":{"system":"sec-edgar","filing":"0001127602-25-015541","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225015541/form4.xml","form_type":"4"}},{"id":1142546,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:43:15.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":22517,"source":{"system":"sec-edgar","filing":"0001062993-25-009809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000106299325009809/form4.xml","form_type":"4"}},{"id":1172488,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-04-14T21:17:43.000Z","date":"2025-04-11","kind":"exercise","planned":false,"acquired":false,"shares":3752,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."}],"balance_after":7503,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3752},"source":{"system":"sec-edgar","filing":"0001127602-25-012018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225012018/form4.xml","form_type":"4"}},{"id":1172487,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-04-14T21:17:43.000Z","date":"2025-04-11","kind":"exercise","planned":false,"acquired":false,"shares":2323,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2323},"source":{"system":"sec-edgar","filing":"0001127602-25-012018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225012018/form4.xml","form_type":"4"}},{"id":1172486,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-04-14T21:17:43.000Z","date":"2025-04-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":901,"price":27,"value":24327.0,"ownership":{"direct":true},"balance_after":4616,"source":{"system":"sec-edgar","filing":"0001127602-25-012018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225012018/form4.xml","form_type":"4"}},{"id":1172485,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-04-14T21:17:43.000Z","date":"2025-04-11","kind":"exercise","planned":false,"acquired":true,"shares":3752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":5517,"source":{"system":"sec-edgar","filing":"0001127602-25-012018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225012018/form4.xml","form_type":"4"}},{"id":1172484,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-04-14T21:17:43.000Z","date":"2025-04-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":27,"value":15066.0,"ownership":{"direct":true},"balance_after":1765,"source":{"system":"sec-edgar","filing":"0001127602-25-012018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225012018/form4.xml","form_type":"4"}},{"id":1172483,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-04-14T21:17:43.000Z","date":"2025-04-11","kind":"exercise","planned":false,"acquired":true,"shares":2323,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":2323,"source":{"system":"sec-edgar","filing":"0001127602-25-012018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760225012018/form4.xml","form_type":"4"}},{"id":1273750,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-11T23:19:20.000Z","date":"2025-02-09","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vests in three annual installments beginning February 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vests in three annual installments beginning February 9, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-25-001134","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025001134/primarydocument.xml","form_type":"4"}},{"id":1273749,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T23:19:20.000Z","date":"2025-02-09","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":205436,"source":{"system":"sec-edgar","filing":"0001562180-25-001134","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025001134/primarydocument.xml","form_type":"4"}},{"id":1281715,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-05T22:30:42.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":12726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on February 4, 2026, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on such date in shares of the Issuer's common stock."}],"balance_after":12726,"source":{"system":"sec-edgar","filing":"0001062993-25-001754","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000106299325001754/form4.xml","form_type":"4"}},{"id":1307902,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-07T21:04:08.000Z","date":"2025-01-06","kind":"exercise","planned":false,"acquired":false,"shares":75134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vests in three ratable annual installments beginning January 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vests in three ratable annual installments beginning January 6, 2024."}],"balance_after":75133,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":75134},"source":{"system":"sec-edgar","filing":"0001562180-25-000228","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025000228/primarydocument.xml","form_type":"4"}},{"id":1307901,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-07T21:04:08.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":12667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vests in three ratable annual installments beginning January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vests in three ratable annual installments beginning January 5, 2025."}],"balance_after":25333,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12667},"source":{"system":"sec-edgar","filing":"0001562180-25-000228","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025000228/primarydocument.xml","form_type":"4"}},{"id":1307900,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T21:04:08.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":8.26,"exercise_date":"2026-01-03","expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-25-000228","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025000228/primarydocument.xml","form_type":"4"}},{"id":1307899,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T21:04:08.000Z","date":"2025-01-06","kind":"exercise","planned":false,"acquired":true,"shares":75134,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":185436,"source":{"system":"sec-edgar","filing":"0001562180-25-000228","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025000228/primarydocument.xml","form_type":"4"}},{"id":1307898,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T21:04:08.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":12667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":110302,"source":{"system":"sec-edgar","filing":"0001562180-25-000228","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218025000228/primarydocument.xml","form_type":"4"}},{"id":1427555,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T20:04:02.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":3173,"price":7.88,"value":25003.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.87 to $7.88. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":97635,"source":{"system":"sec-edgar","filing":"0001562180-24-006378","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024006378/primarydocument.xml","form_type":"4"}},{"id":1448035,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until July 10, 2027."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":16666,"derivative":{"exercise_price":9.11,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448034,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until July 10, 2027."}],"balance_after":50000,"derivative":{"exercise_price":9.11,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448033,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":true,"shares":56350,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 6, 2027."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":169050,"derivative":{"exercise_price":3.26,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":56350},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448032,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":false,"shares":56350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 6, 2027."}],"balance_after":281750,"derivative":{"exercise_price":3.26,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":56350},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448031,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":145000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448030,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."}],"balance_after":95000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448029,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":true,"shares":26713,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":182535,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":26713},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448028,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":false,"shares":26713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025."}],"balance_after":31165,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":26713},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448027,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":true,"shares":1558,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":74800,"derivative":{"exercise_price":12.9,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":1558},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1448026,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T20:47:57.000Z","date":"2024-07-26","kind":"gift","planned":false,"acquired":false,"shares":1558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 26, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full."}],"balance_after":0,"derivative":{"exercise_price":12.9,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":1558},"source":{"system":"sec-edgar","filing":"0001562180-24-005854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005854/primarydocument.xml","form_type":"4"}},{"id":1455257,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Restricted Stock Units","published_at":"2024-07-12T21:03:25.000Z","date":"2024-07-10","kind":"exercise","planned":false,"acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vests in three ratable annual installments beginning July 10, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vests in three ratable annual installments beginning July 10, 2024."}],"balance_after":22223,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001562180-24-005700","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005700/primarydocument.xml","form_type":"4"}},{"id":1455256,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-07-12T21:03:25.000Z","date":"2024-07-10","kind":"exercise","planned":false,"acquired":true,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":94462,"source":{"system":"sec-edgar","filing":"0001562180-24-005700","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024005700/primarydocument.xml","form_type":"4"}},{"id":1491987,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:56:58.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":17492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option award vest and become exercisable in full on 5/31/2025."}],"balance_after":17492,"derivative":{"exercise_price":23.4,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Ordinary Shares","underlying_shares":17492},"source":{"system":"sec-edgar","filing":"0001127602-24-017727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760224017727/form4.xml","form_type":"4"}},{"id":1491986,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-06-04T20:56:58.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":8013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 5/31/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 5/31/2025."}],"balance_after":8013,"derivative":{"exercise_date":"2025-05-31","underlying":"Ordinary Shares","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001127602-24-017727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760224017727/form4.xml","form_type":"4"}},{"id":1542517,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-04-12T20:16:10.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":22103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the stock option award vest in three equal annual installments commencing on 4/11/2025."}],"balance_after":22103,"derivative":{"exercise_price":24.99,"expiration_date":"2034-04-11","underlying":"Ordinary Shares","underlying_shares":22103},"source":{"system":"sec-edgar","filing":"0001127602-24-012829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760224012829/form4.xml","form_type":"4"}},{"id":1542516,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-04-12T20:16:10.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":11255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."}],"balance_after":11255,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11255},"source":{"system":"sec-edgar","filing":"0001127602-24-012829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760224012829/form4.xml","form_type":"4"}},{"id":1542515,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-04-12T20:16:10.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":4833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option award vest and become exercisable in full on 4/11/2025."}],"balance_after":4833,"derivative":{"exercise_price":24.99,"exercise_date":"2025-04-11","expiration_date":"2034-04-11","underlying":"Ordinary Shares","underlying_shares":4833},"source":{"system":"sec-edgar","filing":"0001127602-24-012829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760224012829/form4.xml","form_type":"4"}},{"id":1542514,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-04-12T20:16:10.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":2323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 4/11/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 4/11/2025."}],"balance_after":2323,"derivative":{"exercise_date":"2025-04-11","underlying":"Ordinary Shares","underlying_shares":2323},"source":{"system":"sec-edgar","filing":"0001127602-24-012829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000112760224012829/form4.xml","form_type":"4"}},{"id":1646002,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On February 13, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":115000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1646001,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On February 13, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."}],"balance_after":125000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1646000,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":true,"shares":4452,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On February 13, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":155822,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":4452},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645999,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":false,"shares":4452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On February 13, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025."}],"balance_after":57878,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":4452},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645998,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":true,"shares":3116,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On February 13, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 28, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":73242,"derivative":{"exercise_price":12.9,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":3116},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645997,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":false,"shares":3116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On February 13, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 28, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024."}],"balance_after":1558,"derivative":{"exercise_price":12.9,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":3116},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645996,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Restricted Stock Units","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units will vest in three ratable annual installments beginning February 9, 2023."}],"balance_after":20000,"derivative":{"exercise_price":0,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645995,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Restricted Stock Units","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":17534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in three ratable annual installments beginning February 9, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":17534},"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645994,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":true,"shares":74681,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 13, 2024, the reporting person transferred owned shares of Common Stock of the Company to the Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":126889,"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645993,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-13","kind":"gift","planned":false,"acquired":false,"shares":74681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 13, 2024, the reporting person transferred owned shares of Common Stock of the Company to the Family Trust."}],"balance_after":83351,"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645992,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":6981,"price":28.8,"value":201052.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units"}],"balance_after":158032,"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645991,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":7962,"price":28.8,"value":229305.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units"}],"balance_after":165013,"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645990,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":17534,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":172975,"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1645989,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-02-13T22:40:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":155441,"source":{"system":"sec-edgar","filing":"0001562180-24-001294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024001294/primarydocument.xml","form_type":"4"}},{"id":1670881,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T23:24:43.000Z","date":"2024-01-24","kind":"gift","planned":true,"acquired":true,"shares":112700,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On January 24, 2024, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on January 6, 2023 and was exercisable for 112,700 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 112,700 shares of Common Stock of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase vests and becomes exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":112700,"derivative":{"exercise_price":3.26,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":112700},"source":{"system":"sec-edgar","filing":"0001562180-24-000636","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000636/primarydocument.xml","form_type":"4"}},{"id":1670880,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T23:24:43.000Z","date":"2024-01-24","kind":"gift","planned":true,"acquired":false,"shares":112700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On January 24, 2024, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on January 6, 2023 and was exercisable for 112,700 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 112,700 shares of Common Stock of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase vests and becomes exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years."}],"balance_after":338100,"derivative":{"exercise_price":3.26,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":112700},"source":{"system":"sec-edgar","filing":"0001562180-24-000636","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000636/primarydocument.xml","form_type":"4"}},{"id":1670879,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-01-25T23:24:43.000Z","date":"2024-01-24","kind":"sale","planned":true,"acquired":false,"shares":29956,"price":24.9783,"value":748249.9548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.95 to $25.24. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of  EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":135441,"source":{"system":"sec-edgar","filing":"0001562180-24-000636","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000636/primarydocument.xml","form_type":"4"}},{"id":1670878,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-01-25T23:24:43.000Z","date":"2024-01-23","kind":"sale","planned":true,"acquired":false,"shares":5044,"price":24.9702,"value":125949.6888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.95 to $25.00. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of  EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":165397,"source":{"system":"sec-edgar","filing":"0001562180-24-000636","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000636/primarydocument.xml","form_type":"4"}},{"id":1682619,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Restricted Stock Units","published_at":"2024-01-10T02:17:24.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":false,"shares":75133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vests in three ratable annual installments beginning January 6, 2024."}],"balance_after":150267,"derivative":{"exercise_price":0,"expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":75133},"source":{"system":"sec-edgar","filing":"0001562180-24-000402","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000402/primarydocument.xml","form_type":"4"}},{"id":1682618,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-10T02:17:24.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option to purchase will vest and become exercisable as follows: 25% at January 5th, 2025 and the remainder ratably, on a monthly basis, over the remaining three years."}],"balance_after":77000,"derivative":{"exercise_price":20.4,"expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001562180-24-000402","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000402/primarydocument.xml","form_type":"4"}},{"id":1682617,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Restricted Stock Units","published_at":"2024-01-10T02:17:24.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in three ratable annual installments beginning January 5, 2025."}],"balance_after":38000,"derivative":{"exercise_price":0,"expiration_date":"2034-01-05","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001562180-24-000402","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000402/primarydocument.xml","form_type":"4"}},{"id":1682616,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-01-10T02:17:24.000Z","date":"2024-01-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":23043,"price":20.4,"value":470077.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units"}],"balance_after":170441,"source":{"system":"sec-edgar","filing":"0001562180-24-000402","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000402/primarydocument.xml","form_type":"4"}},{"id":1682615,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-01-10T02:17:24.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":true,"shares":75133,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":193484,"source":{"system":"sec-edgar","filing":"0001562180-24-000402","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000402/primarydocument.xml","form_type":"4"}},{"id":1692078,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"On December 28, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 9, 2022 and was exercisable for 240,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 110,000 shares of Common Stock of the Company, of which 75,000 had been previously gifted on May 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of December 9, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":110000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}},{"id":1692077,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"On December 28, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 9, 2022 and was exercisable for 240,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 110,000 shares of Common Stock of the Company, of which 75,000 had been previously gifted on May 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of December 9, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026."}],"balance_after":130000,"derivative":{"exercise_price":10.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}},{"id":1692076,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":true,"shares":10906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On December 28, 2023, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\"). The option was originally granted to the reporting person on February 28, 2020 and was exercisable for 74,800 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 71,684 shares of Common Stock of the Company, of which 59,220 had been previously gifted on May 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of April 28, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":70126,"derivative":{"exercise_price":12.9,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":10906},"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}},{"id":1692075,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":false,"shares":10906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On December 28, 2023, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share (\"Common Stock\"), of EyePoint Pharmaceuticals, Inc. (the \"Company\"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the \"Family Trust\"). The option was originally granted to the reporting person on February 28, 2020 and was exercisable for 74,800 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 71,684 shares of Common Stock of the Company, of which 59,220 had been previously gifted on May 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of April 28, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024."}],"balance_after":4674,"derivative":{"exercise_price":12.9,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":10906},"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}},{"id":1692074,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":true,"shares":31164,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On December 28, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 9, 2021 and was exercisable for 213,700 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 151,370 shares of Common Stock of the Company, of which 120,206 had been previously gifted on May 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of December 9, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":151370,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":31164},"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}},{"id":1692073,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":false,"shares":31164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On December 28, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 9, 2021 and was exercisable for 213,700 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 151,370 shares of Common Stock of the Company, of which 120,206 had been previously gifted on May 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of December 9, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025."}],"balance_after":62330,"derivative":{"exercise_price":13.13,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":31164},"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}},{"id":1692072,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":true,"shares":52208,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction was inadvertently left off of the original Form 4 filing on January 2, 2024."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 28, 2023, the reporting person transferred owned shares of Common Stock of the Company to the Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":52208,"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}},{"id":1692071,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chair"}}],"security":"Common Stock","published_at":"2024-01-03T23:37:05.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":false,"shares":52208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction was inadvertently left off of the original Form 4 filing on January 2, 2024."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 28, 2023, the reporting person transferred owned shares of Common Stock of the Company to the Family Trust."}],"balance_after":118351,"source":{"system":"sec-edgar","filing":"0001562180-24-000133","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000156218024000133/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-01-02"}}],"next_cursor":"2024-01-03T23:37:05.000000Z,1692071"}